Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,901 to 1,920 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications. | Bioconjug Chem | 2019 | 30608140 | PubTator, text mining | PubMed |
| Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias. | Neurotherapeutics | 2019 | 30607747 | PubTator, text mining | PubMed |
| Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol. | J Med Genet | 2019 | 30593463 | PubTator, text mining | PubMed |
| Composition of the Survival Motor Neuron (SMN) Complex in Drosophila melanogaster. | G3 (Bethesda) | 2019 | 30563832 | PubTator, text mining | PubMed |
| Reanalysis and optimisation of bioinformatic pipelines is critical for mutation detection. | Hum Mutat | 2019 | 30556619 | PubTator, text mining | PubMed |
The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy. | Neuromuscul Disord | 2019 | 30553700 | PubTator, text mining | PubMed |
| Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. | Pediatr Pulmonol | 2019 | 30548438 | PubTator, text mining | PubMed |
| Overexpression of SMN2 Gene in Motoneuron-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells by Ponasterone A. | J Mol Neurosci | 2019 | 30535775 | PubTator, text mining | PubMed |
| The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging study. | Neuroimage Clin | 2019 | 30522974 | PubTator, text mining | PubMed |
| Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy. | Hum Mol Genet | 2019 | 30481286 | PubTator, text mining | PubMed |
| Restricted and Repetitive Behavior and Brain Functional Connectivity in Infants at Risk for Developing Autism Spectrum Disorder. | Biol Psychiatry Cogn Neurosci Neuroimaging | 2019 | 30446435 | PubTator, text mining | PubMed |
| Neurotheranostics as personalized medicines. | Adv Drug Deliv Rev | 2019 | 30421721 | PubTator, text mining | PubMed |
| Amish nemaline myopathy and dilated cardiomyopathy caused by a homozygous contiguous gene deletion of TNNT1 and TNNI3 in a Mennonite child. | Eur J Med Genet | 2019 | 30395933 | PubTator, text mining | PubMed |
| A Heterologous Cell Model for Studying the Role of T-Cell Intracellular Antigen 1 in Welander Distal Myopathy. | Mol Cell Biol | 2019 | 30348840 | PubTator, text mining | PubMed |
| Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice. | Mol Neurobiol | 2019 | 30327977 | PubTator, text mining | PubMed |
| Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment. | Nucleic Acid Ther | 2019 | 30307373 | PubTator, text mining | PubMed |
| A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier. | Br J Clin Pharmacol | 2019 | 30302786 | PubTator, text mining | PubMed |
| Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps. | Dev Med Child Neurol | 2019 | 30221755 | PubTator, text mining | PubMed |
| High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids' Inpatient Database (KID). | Pharmacoecon Open | 2019 | 30182345 | PubTator, text mining | PubMed |
| Incidence of infantile spinal muscular atrophy on Shikoku Island of Japan. | Brain Dev | 2019 | 30093179 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=96